A detailed history of Planning Capital Management Corp transactions in Novartis Ag stock. As of the latest transaction made, Planning Capital Management Corp holds 257 shares of NVS stock, worth $27,789. This represents 0.02% of its overall portfolio holdings.

Number of Shares
257
Previous 279 7.89%
Holding current value
$27,789
Previous $28.2 Million 11.75%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

SELL
$95.27 - $108.47 $2,095 - $2,386
-22 Reduced 7.89%
257 $24.9 Million
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $25,743 - $28,329
279 New
279 $28.2 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $233B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Planning Capital Management Corp Portfolio

Follow Planning Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planning Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Planning Capital Management Corp with notifications on news.